ZURA Zura Bio Ltd
Price (delayed)
$1.17
Market cap
$80M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.6
Enterprise value
-$96.5M
zura bio is a clinical-stage biotechnology company advancing zb-168 in alopecia areata and other inflammatory diseases. zb-168 is an anti il7rα inhibitor that has the potential to impact diseases driven
Highlights
The company's equity has surged by 147% YoY but it fell by 4.1% QoQ
The EPS has dropped by 88% since the previous quarter but it has soared by 71% year-on-year
Key stats
What are the main financial stats of ZURA
Market
Valuations
Earnings
Shares outstanding
68.37M
Market cap
$80M
Enterprise value
-$96.5M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.52
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$55.19M
Net income
-$52.4M
EBIT
-$52.4M
EBITDA
-$52.39M
Free cash flow
-$28.15M
Per share
Balance sheet
Liquidity
EPS
-$0.6
EPS diluted
-$0.6
Free cash flow per share
-$0.37
Book value per share
$2.25
Revenue per share
$0
TBVPS
$2.39
Total assets
$179.53M
Total liabilities
$19.51M
Debt
$0
Equity
$146.82M
Working capital
$159.23M
Debt to equity
0
Current ratio
9.16
Quick ratio
9.04
Net debt/EBITDA
3.37
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-28%
Return on equity
-35.1%
Return on invested capital
N/A
Return on capital employed
-32.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ZURA stock price
How has the Zura Bio stock price performed over time
Intraday
-1.27%
1 week
-12.36%
1 month
-13.97%
1 year
-60.07%
YTD
-53.2%
QTD
-9.3%
Financial performance
How have Zura Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$55.19M
Net income
-$52.4M
Gross margin
N/A
Net margin
N/A
ZURA's net income is up by 13% year-on-year but it is down by 11% since the previous quarter
The operating income rose by 12% YoY but it fell by 10% QoQ
Growth
What is Zura Bio's growth rate over time
Valuation
What is Zura Bio stock price valuation
P/E
N/A
P/B
0.52
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has dropped by 88% since the previous quarter but it has soared by 71% year-on-year
The company's equity has surged by 147% YoY but it fell by 4.1% QoQ
The price to book (P/B) is 62% less than the last 4 quarters average of 1.4
Efficiency
How efficient is Zura Bio business performance
Zura Bio's ROE has soared by 72% YoY and by 12% from the previous quarter
The return on assets has surged by 63% year-on-year and by 6% since the previous quarter
Dividends
What is ZURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ZURA.
Financial health
How did Zura Bio financials performed over time
The quick ratio has surged by 84% year-on-year but it has declined by 12% since the previous quarter
Zura Bio's current ratio has surged by 84% YoY but it has decreased by 12% QoQ
The debt is 100% smaller than the equity
The company's equity has surged by 147% YoY but it fell by 4.1% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.